Eli Lilly & Co. (LLY) Misses Q3 EPS by 27c; guides below consensus
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,098.57 -1.21%
EPS Growth %: +39.6%
Financial Fact:
Marketing, selling, and administrative: 1.57B
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +39.6%
Financial Fact:
Marketing, selling, and administrative: 1.57B
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Eli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $1.18, $0.27 worse than the analyst estimate of $1.45. Revenue for the quarter came in at $11.44 billion versus the consensus estimate of $12.09 billion.
GUIDANCE:
Eli Lilly & Co. sees FY2024 EPS of $13.02-$13.52, versus the consensus of $13.50. Eli Lilly & Co. sees FY2024 revenue of $45.4-46 billion, versus the consensus of $46.25 billion.
For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron Technology (MU) PT Raised to $1,300 at Bernstein SocGen Group
- MDA Space Ltd (MDA:CN) (MDA) PT Raised to Cdn$68 at BMO Capital
- JPMorgan Downgrades Anima Holding SA (ANIM3:BZ) to Neutral
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
